+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anterior Uveitis Treatment Market Research Report by Treatment Type (Anti-TNF Agents, Corticosteroids, and Cycloplegic Agents), Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5292910
  • Report
  • April 2022
  • Region: Global
  • 218 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • AbbVie Inc.
  • Akorn Pvt. Ltd
  • Amgen Inc.
  • Hanall Biopharma
  • Novartis AG
  • Sirion Therapeutics, Inc.
The Global Anterior Uveitis Treatment Market size was estimated at USD 217.77 million in 2021, USD 235.81 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.45% to reach USD 354.46 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Anterior Uveitis Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment Type, the market was studied across Anti-TNF Agents, Corticosteroids, Cycloplegic Agents, and Immunosuppressants.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Anterior Uveitis Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anterior Uveitis Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Anterior Uveitis Treatment Market, including AbbVie Inc., Aciont Inc., Akorn Pvt. Ltd, Aldeyra Therapeutics, Inc., Alimera Sciences Inc., Amdipharm Mercury Company Limited, Amgen Inc., Bausch & Lomb Incorporated, Clearside Biomedical, Inc., Enzo Biochem Inc, Eyegate Pharmaceuticals, Inc., Hanall Biopharma, Lux Biosciences, Inc, Novartis AG, Ophthalix Inc, Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co. Ltd, Sirion Therapeutics, Inc., TopiVert Pharma Limited, UAB Medicine, UCB Biopharma S.P.R.L., Wize Pharma Inc, and Xoma Corporation.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Anterior Uveitis Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anterior Uveitis Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anterior Uveitis Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Anterior Uveitis Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Anterior Uveitis Treatment Market?
6. What is the market share of the leading vendors in the Global Anterior Uveitis Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Anterior Uveitis Treatment Market?
Frequently Asked Questions about the Global Anterior Uveitis Treatment Market

What is the estimated value of the Global Anterior Uveitis Treatment Market?

The Global Anterior Uveitis Treatment Market was estimated to be valued at $217.8 Million in 2021.

What is the growth rate of the Global Anterior Uveitis Treatment Market?

The growth rate of the Global Anterior Uveitis Treatment Market is 8.4%, with an estimated value of $354.5 Million by 2027.

What is the forecasted size of the Global Anterior Uveitis Treatment Market?

The Global Anterior Uveitis Treatment Market is estimated to be worth $354.5 Million by 2027.

Who are the key companies in the Global Anterior Uveitis Treatment Market?

Key companies in the Global Anterior Uveitis Treatment Market include AbbVie Inc., Aciont Inc., Akorn Pvt. Ltd, Aldeyra Therapeutics, Inc., Alimera Sciences Inc., Amdipharm Mercury Company Limited, Amgen Inc., Bausch & Lomb Incorporated and Enzo Biochem Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Akorn Pvt. Ltd
  • Amgen Inc.
  • Hanall Biopharma
  • Novartis AG
  • Sirion Therapeutics, Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of eye infections
5.1.1.2. Rising expenditure on the research and development of novel drugs and treatments for Uveitis
5.1.2. Restraints
5.1.2.1. High cost associated with the medications
5.1.2.2. Limited knowledge about eye disorders
5.1.3. Opportunities
5.1.3.1. Development of research companies on biological drugs
5.1.3.2. Growing demand for drugs such as corticosteroids and anti-inflammatory medications in developing countries
5.1.4. Challenges
5.1.4.1. Side effect associated with corticosteroid treatment
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Anterior Uveitis Treatment Market, by Treatment Type
6.1. Introduction
6.2. Anti-TNF Agents
6.3. Corticosteroids
6.4. Cycloplegic Agents
6.5. Immunosuppressants
7. Anterior Uveitis Treatment Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Pharmacies
7.4. Retail Pharmacies
8. Americas Anterior Uveitis Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Anterior Uveitis Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Anterior Uveitis Treatment Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AbbVie Inc.
12.2. Aciont Inc.
12.3. Akorn Pvt. Ltd
12.4. Aldeyra Therapeutics, Inc.
12.5. Alimera Sciences Inc.
12.6. Amdipharm Mercury Company Limited
12.7. Amgen Inc.
12.8. Bausch & Lomb Incorporated
12.9. Clearside Biomedical, Inc.
12.10. Enzo Biochem Inc
12.11. Eyegate Pharmaceuticals, Inc.
12.12. Hanall Biopharma
12.13. Lux Biosciences, Inc
12.14. Novartis AG
12.15. Ophthalix Inc
12.16. Regeneron Pharmaceuticals, Inc.
12.17. Santen Pharmaceutical Co., Ltd.
12.18. Senju Pharmaceutical Co. Ltd
12.19. Sirion Therapeutics, Inc.
12.20. TopiVert Pharma Limited
12.21. UAB Medicine
12.22. UCB Biopharma S.P.R.L.
12.23. Wize Pharma Inc
12.24. Xoma Corporation
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: DYNAMICS
FIGURE 2. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2027
FIGURE 5. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 14. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 16. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 23. ARGENTINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 24. BRAZIL ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 25. CANADA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 26. MEXICO ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. AUSTRALIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. CHINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. INDIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. INDONESIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. JAPAN ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. MALAYSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. PHILIPPINES ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. SINGAPORE ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. SOUTH KOREA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. TAIWAN ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. THAILAND ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. FRANCE ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. GERMANY ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. ITALY ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. NETHERLANDS ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. QATAR ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. RUSSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. SAUDI ARABIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. SOUTH AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. SPAIN ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. UNITED ARAB EMIRATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. UNITED KINGDOM ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 54. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTERIOR UVEITIS TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. ARGENTINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. BRAZIL ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. CANADA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. MEXICO ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. AUSTRALIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. CHINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. INDIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. INDONESIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. JAPAN ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. MALAYSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. PHILIPPINES ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. SINGAPORE ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. SOUTH KOREA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. TAIWAN ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. THAILAND ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. FRANCE ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. GERMANY ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. ITALY ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. NETHERLANDS ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. QATAR ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. RUSSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. SAUDI ARABIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. SOUTH AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. SPAIN ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. UNITED ARAB EMIRATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. UNITED KINGDOM ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: SCORES
TABLE 71. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: BUSINESS STRATEGY
TABLE 72. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 73. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: RANKING
TABLE 74. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 75. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: MERGER & ACQUISITION
TABLE 76. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 77. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 78. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 79. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 80. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Aciont Inc.
  • Akorn Pvt. Ltd
  • Aldeyra Therapeutics, Inc.
  • Alimera Sciences Inc.
  • Amdipharm Mercury Company Limited
  • Amgen Inc.
  • Bausch & Lomb Incorporated
  • Clearside Biomedical, Inc.
  • Enzo Biochem Inc
  • Eyegate Pharmaceuticals, Inc.
  • Hanall Biopharma
  • Lux Biosciences, Inc
  • Novartis AG
  • Ophthalix Inc
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Senju Pharmaceutical Co. Ltd
  • Sirion Therapeutics, Inc.
  • TopiVert Pharma Limited
  • UAB Medicine
  • UCB Biopharma S.P.R.L.
  • Wize Pharma Inc
  • Xoma Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...